PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Fidelity Select Medical Technology and Devices Por...
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Fund Info

ISINUS3163904754
CUSIP316390475
IssuerFidelity
Inception DateApr 28, 1998
CategoryHealth & Biotech Equities
Home Pagefundresearch.fidelity.com
Asset ClassEquity

Asset Class Size

Large-Cap

Asset Class Style

Growth

Expense Ratio

FSMEX has a high expense ratio of 0.68%, indicating higher-than-average management fees.


Expense ratio chart for FSMEX: current value at 0.68% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.68%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Fidelity Select Medical Technology and Devices Portfolio

Popular comparisons: FSMEX vs. FSHCX, FSMEX vs. IHT, FSMEX vs. XLV, FSMEX vs. SPY, FSMEX vs. FXAIX, FSMEX vs. VOO, FSMEX vs. VONG, FSMEX vs. BST, FSMEX vs. DIA, FSMEX vs. FNILX

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Fidelity Select Medical Technology and Devices Portfolio, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


500.00%1,000.00%1,500.00%2,000.00%2,500.00%December2024FebruaryMarchAprilMay
2,647.06%
378.46%
FSMEX (Fidelity Select Medical Technology and Devices Portfolio)
Benchmark (^GSPC)

S&P 500

Returns By Period

Fidelity Select Medical Technology and Devices Portfolio had a return of 6.82% year-to-date (YTD) and 3.34% in the last 12 months. Over the past 10 years, Fidelity Select Medical Technology and Devices Portfolio had an annualized return of 13.61%, outperforming the S&P 500 benchmark which had an annualized return of 10.90%.


PeriodReturnBenchmark
Year-To-Date6.82%11.05%
1 month2.69%4.86%
6 months20.06%17.50%
1 year3.34%27.37%
5 years (annualized)9.25%13.14%
10 years (annualized)13.61%10.90%

Monthly Returns

The table below presents the monthly returns of FSMEX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20242.36%3.94%2.50%-4.82%6.82%
20233.26%-3.07%4.92%1.22%-4.84%5.02%-0.50%-4.33%-8.05%-9.92%10.24%8.97%0.62%
2022-14.16%-0.80%2.44%-13.32%-2.18%-5.25%10.28%-6.30%-5.26%3.47%7.24%-1.27%-24.83%
20214.67%-1.63%-0.00%7.98%-3.51%6.27%6.13%4.23%-4.13%5.09%-5.51%3.75%24.56%
20200.27%-7.39%-7.43%14.54%4.74%2.13%10.99%0.36%0.76%1.01%5.17%3.68%30.18%
20198.65%3.02%1.59%-2.92%-1.19%9.54%0.21%-1.18%-1.45%2.10%6.25%2.43%29.58%
20189.30%-3.88%0.35%3.49%4.79%3.01%3.13%7.45%3.17%-10.41%5.08%-8.51%15.98%
20177.03%5.25%1.81%3.24%1.27%5.30%-1.53%1.54%-0.84%1.64%2.94%-3.28%26.66%
2016-6.80%0.96%4.09%6.74%1.56%5.90%6.45%0.73%0.63%-7.60%-4.61%1.65%8.69%
20151.31%6.53%2.63%-2.08%2.98%-1.42%2.41%-5.86%-6.90%5.72%2.65%0.96%8.28%
20143.08%3.23%0.82%-3.96%3.57%6.00%-1.23%1.67%-2.22%8.47%3.84%2.71%28.49%
20139.86%-0.13%3.76%-0.70%4.21%-0.06%6.76%-2.80%3.90%5.70%3.49%2.58%42.43%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of FSMEX is 5, indicating that it is in the bottom 5% of mutual funds on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of FSMEX is 55
FSMEX (Fidelity Select Medical Technology and Devices Portfolio)
The Sharpe Ratio Rank of FSMEX is 55Sharpe Ratio Rank
The Sortino Ratio Rank of FSMEX is 55Sortino Ratio Rank
The Omega Ratio Rank of FSMEX is 55Omega Ratio Rank
The Calmar Ratio Rank of FSMEX is 55Calmar Ratio Rank
The Martin Ratio Rank of FSMEX is 44Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


FSMEX
Sharpe ratio
The chart of Sharpe ratio for FSMEX, currently valued at 0.18, compared to the broader market-1.000.001.002.003.004.000.18
Sortino ratio
The chart of Sortino ratio for FSMEX, currently valued at 0.38, compared to the broader market-2.000.002.004.006.008.0010.0012.000.38
Omega ratio
The chart of Omega ratio for FSMEX, currently valued at 1.04, compared to the broader market0.501.001.502.002.503.003.501.04
Calmar ratio
The chart of Calmar ratio for FSMEX, currently valued at 0.07, compared to the broader market0.002.004.006.008.0010.0012.000.07
Martin ratio
The chart of Martin ratio for FSMEX, currently valued at 0.32, compared to the broader market0.0020.0040.0060.0080.000.32
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.49, compared to the broader market-1.000.001.002.003.004.002.49
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.52, compared to the broader market-2.000.002.004.006.008.0010.0012.003.52
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.43, compared to the broader market0.501.001.502.002.503.003.501.43
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.03, compared to the broader market0.002.004.006.008.0010.0012.002.03
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.57, compared to the broader market0.0020.0040.0060.0080.009.57

Sharpe Ratio

The current Fidelity Select Medical Technology and Devices Portfolio Sharpe ratio is 0.18. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Fidelity Select Medical Technology and Devices Portfolio with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
0.18
2.49
FSMEX (Fidelity Select Medical Technology and Devices Portfolio)
Benchmark (^GSPC)

Dividends

Dividend History

Fidelity Select Medical Technology and Devices Portfolio granted a 2.03% dividend yield in the last twelve months. The annual payout for that period amounted to $1.32 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend$1.32$0.00$1.11$6.76$4.84$1.06$3.53$2.75$2.15$5.87$6.03$3.52

Dividend yield

2.03%0.00%1.80%8.12%6.65%1.77%7.47%6.26%5.84%16.35%15.54%9.84%

Monthly Dividends

The table displays the monthly dividend distributions for Fidelity Select Medical Technology and Devices Portfolio. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$1.32$0.00$1.32
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$1.11$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.11
2021$0.00$0.00$0.00$3.63$0.00$0.00$0.00$0.00$0.00$0.00$0.00$3.12$6.76
2020$0.00$0.00$0.00$1.30$0.00$0.00$0.00$0.00$0.00$0.00$0.00$3.54$4.84
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.06$1.06
2018$0.00$0.00$0.00$1.92$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.61$3.53
2017$0.00$0.00$0.00$0.20$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.55$2.75
2016$0.00$0.00$0.00$0.30$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.86$2.15
2015$0.00$0.00$0.00$4.20$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.67$5.87
2014$0.00$0.00$0.00$1.96$0.00$0.00$0.00$0.00$0.00$0.00$0.00$4.07$6.03
2013$0.42$0.00$0.00$0.00$0.00$0.00$0.00$0.00$3.10$3.52

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%December2024FebruaryMarchAprilMay
-21.84%
-0.21%
FSMEX (Fidelity Select Medical Technology and Devices Portfolio)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Fidelity Select Medical Technology and Devices Portfolio. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Fidelity Select Medical Technology and Devices Portfolio was 40.34%, occurring on Oct 30, 2023. The portfolio has not yet recovered.

The current Fidelity Select Medical Technology and Devices Portfolio drawdown is 21.84%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-40.34%Sep 8, 2021540Oct 30, 2023
-40.16%Aug 25, 200863Nov 20, 2008333Mar 22, 2010396
-33.04%Feb 20, 202023Mar 23, 202071Jul 2, 202094
-26.38%Dec 29, 2000388Jul 23, 2002192Apr 28, 2003580
-23.19%May 20, 2011132Nov 25, 2011214Oct 3, 2012346

Volatility

Volatility Chart

The current Fidelity Select Medical Technology and Devices Portfolio volatility is 5.20%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%December2024FebruaryMarchAprilMay
5.20%
3.40%
FSMEX (Fidelity Select Medical Technology and Devices Portfolio)
Benchmark (^GSPC)